
FDA ApprovedUnited States
New Infusion When Soft Tissue Turns to Bone (Adult FOP)
Pasatru (garetosmab-grts) for adults with fibrodysplasia ossificans progressiva (FOP)
The FDA labelled an intravenous activin A–blocking monoclonal antibody on 19 August 2026 to reduce formation of new heterotopic ossification (HO)…
The FDA labelled an intravenous activin A–blocking monoclonal antibody on 19 August 2026 to reduce…